Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Aspen Pharmacare (APNHY)

OTHER OTC:APNHY

APNHY

Aspen Pharmacare

RESEARCH TOOLSreports

Aspen Pharmacare (APNHY) Ratios

Compare

23 Followers

Aspen Pharmacare Ratios

APNHY's free cash flow for Q2 2026 was Rs0.44. For the 2026 fiscal year, APNHY's free cash flow was decreased by Rs and operating cash flow was Rs0.18. See a summary of the company’s cash flow.

Ratios	TTM	Jun 25	Jun 24	Jun 23	Jun 22
Liquidity Ratios
Current Ratio	3.64	2.21	1.81	1.92	1.48
Quick Ratio	2.66	1.18	1.07	1.08	0.80
Cash Ratio	0.36	0.37	0.51	0.47	0.26
Solvency Ratio	<0.01	>-0.01	0.12	0.14	0.19
Operating Cash Flow Ratio	0.44	0.29	0.26	0.24	0.23
Short-Term Operating Cash Flow Coverage	1.92	1.12	0.56	0.71	0.47
Net Current Asset Value	Rs 10.37B	Rs -12.30B	Rs -10.21B	Rs -3.55B	Rs -5.87B
Leverage Ratios
Debt-to-Assets Ratio	0.26	0.27	0.26	0.22	0.20
Debt-to-Equity Ratio	0.41	0.43	0.43	0.34	0.31
Debt-to-Capital Ratio	0.29	0.30	0.30	0.25	0.24
Long-Term Debt-to-Capital Ratio	0.27	0.27	0.23	0.20	0.13
Financial Leverage Ratio	1.58	1.60	1.64	1.56	1.57
Debt Service Coverage Ratio	0.25	0.19	0.65	0.98	0.67
Interest Coverage Ratio	3.54	0.87	3.14	5.91	11.33
Debt to Market Cap	0.58	0.68	0.36	0.36	0.33
Interest Debt Per Share	78.01	85.03	87.08	68.90	50.80
Net Debt to EBITDA	15.14	13.75	2.44	1.80	1.62
Profitability Margins
Gross Profit Margin	41.91%	44.11%	43.43%	45.22%	47.42%
EBIT Margin	-0.52%	3.52%	17.76%	21.93%	22.64%
EBITDA Margin	4.69%	4.98%	22.16%	25.03%	25.73%
Operating Profit Margin	16.01%	3.31%	15.65%	19.21%	22.46%
Pretax Profit Margin	-5.59%	-0.28%	12.78%	16.10%	21.07%
Net Profit Margin	-5.19%	-2.50%	9.85%	12.84%	16.81%
Continuous Operations Profit Margin	-6.77%	-2.50%	9.85%	12.84%	16.81%
Net Income Per EBT	92.85%	880.49%	77.07%	79.76%	79.76%
EBT Per EBIT	-34.95%	-8.56%	81.65%	83.80%	93.81%
Return on Assets (ROA)	-1.56%	-0.80%	3.16%	3.89%	5.83%
Return on Equity (ROE)	-2.41%	-1.28%	5.19%	6.06%	9.15%
Return on Capital Employed (ROCE)	5.49%	1.21%	6.10%	7.04%	9.86%
Return on Invested Capital (ROIC)	5.32%	1.17%	4.28%	5.24%	6.94%
Return on Tangible Assets	-2.48%	-1.71%	6.54%	7.97%	12.31%
Earnings Yield	-3.50%	-2.03%	4.40%	6.41%	9.80%
Efficiency Ratios
Receivables Turnover	68.35	3.25	3.90	4.04	4.68
Payables Turnover	2.90	2.27	5.78	5.62	5.58
Inventory Turnover	1.45	1.35	1.40	1.14	1.29
Fixed Asset Turnover	1.87	2.00	2.18	2.15	2.38
Asset Turnover	0.30	0.32	0.32	0.30	0.35
Working Capital Turnover Ratio	1.23	2.12	2.18	2.50	10.84
Cash Conversion Cycle	131.62	222.74	290.32	346.37	295.89
Days of Sales Outstanding	5.34	112.28	93.61	90.44	77.93
Days of Inventory Outstanding	252.35	271.24	259.82	320.89	283.42
Days of Payables Outstanding	126.07	160.78	63.10	64.96	65.47
Operating Cycle	257.69	383.52	353.42	411.33	361.36
Cash Flow Ratios
Operating Cash Flow Per Share	15.59	11.61	14.01	12.43	11.86
Free Cash Flow Per Share	9.95	0.23	1.55	5.27	5.91
CapEx Per Share	5.64	11.38	12.46	7.16	5.95
Free Cash Flow to Operating Cash Flow	0.64	0.02	0.11	0.42	0.50
Dividend Paid and CapEx Coverage Ratio	2.01	0.78	0.88	1.19	1.38
Capital Expenditure Coverage Ratio	2.76	1.02	1.12	1.74	1.99
Operating Cash Flow Coverage Ratio	0.21	0.14	0.17	0.19	0.24
Operating Cash Flow to Sales Ratio	0.18	0.12	0.14	0.14	0.14
Free Cash Flow Yield	7.76%	0.20%	0.69%	2.87%	4.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-28.56	-49.22	22.73	15.61	10.21
Price-to-Sales (P/S) Ratio	1.48	1.23	2.24	2.01	1.72
Price-to-Book (P/B) Ratio	0.70	0.63	1.18	0.95	0.93
Price-to-Free Cash Flow (P/FCF) Ratio	12.89	512.59	145.09	34.90	24.74
Price-to-Operating Cash Flow Ratio	8.24	10.33	16.08	14.79	12.32
Price-to-Earnings Growth (PEG) Ratio	0.34	0.39	-1.44	-0.88	0.28
Price-to-Fair Value	0.70	0.63	1.18	0.95	0.93
Enterprise Value Multiple	46.73	38.42	12.54	9.81	8.28
Enterprise Value	84.34B	83.02B	124.23B	99.99B	82.29B
EV to EBITDA	46.73	38.42	12.54	9.81	8.28
EV to Sales	2.19	1.91	2.78	2.46	2.13
EV to Free Cash Flow	19.06	798.27	180.04	42.75	30.74
EV to Operating Cash Flow	12.17	16.09	19.96	18.11	15.31
Tangible Book Value Per Share	75.78	28.09	29.37	39.48	27.12
Shareholders’ Equity Per Share	182.38	191.11	191.04	194.14	156.60
Tax and Other Ratios
Effective Tax Rate	-0.21	-7.80	0.23	0.20	0.20
Revenue Per Share	86.55	97.62	100.64	91.65	85.22
Net Income Per Share	-4.50	-2.44	9.91	11.77	14.32
Tax Burden	0.93	8.80	0.77	0.80	0.80
Interest Burden	10.71	-0.08	0.72	0.73	0.93
Research & Development to Revenue	0.00	0.00	<0.01	<0.01	0.01
SG&A to Revenue	0.05	0.09	0.08	0.04	0.04
Stock-Based Compensation to Revenue	0.00	0.00	<0.01	<0.01	<0.01
Income Quality	-2.66	3.59	0.89	0.71	0.62

Currency in ZAR